Gilead says draft of coronavirus treatment results contains ‘inappropriate characterization’ and are ‘inconclusive’

Gilead Sciences said that a draft document showing disappointing results from a closely watched clinical trial of the company’s treatment for the coronavirus contained “inappropriate characterizations” and that the study’s findings were “inconclusive.” CNBC